XML 46 R37.htm IDEA: XBRL DOCUMENT
v3.22.1

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Equity [Abstract] |
SCHEDULE OF STOCK OPTION PLAN ACTIVITY | A summary of stock option activity under the Plans for the three months ended March 31, 2022 is as follows: SCHEDULE OF STOCK OPTION PLAN ACTIVITY
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |  |  | Aggregate Intrinsic Value |
Options outstanding – January 1, 2022 |  |  | 3,039,546 |  |  | $ | 5.52 |  |  |  |  |  |  |  |  |
Options granted |  |  | 170,250 |  |  | $ | 7.60 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (126,000 | ) |  | $ | 2.41 |  |  |  |  |  |  |  |  |
Options cancelled/forfeited |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |
Options outstanding – March 31, 2022 |  |  | 3,083,796 |  |  | $ | 5.76 |  |  |  | 5.01 |  |  | $ | 4,781,000 |
Options exercisable |  |  | 2,408,629 |  |  | $ | 5.29 |  |  |  | 4.61 |  |  | $ | 4,639,000 |
Options vested and expected to vest |  |  | 3,083,796 |  |  | $ | 5.76 |  |  |  | 5.01 |  |  | $ | 4,781,000 |
SCHEDULE OF FAIR VALUE ASSUMPTIONS | The table below illustrates the fair value per share determined using the Black-Scholes-Merton option pricing model with the following assumptions used for valuing options granted to employees: SCHEDULE OF FAIR VALUE ASSUMPTIONS
|  | 2022 |
Weighted-average fair value of options granted |  | $ | 4.65 |
Expected terms (in years) |  |  | 6.11 |
Expected volatility |  |  | 70 | %
Risk-free interest rate |  |  | 1.54 | %
Dividend yield |  |  | - |
SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE | The following table summarizes information about stock options outstanding and exercisable at March 31, 2022: SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE
|  |  | Options Outstanding |  |  | Options Exercisable |
Range of Exercise Prices |  |  | Number Outstanding |  |  | Weighted Average Remaining Contractual Life in Years |  |  | Weighted Average Exercise Price |  |  | Number Exercisable |  |  | Weighted Average Exercise Price |
$ | 1.47 - $1.73 |  |  |  | 312,887 |  |  |  | 5.70 |  |  | $ | 1.72 |  |  |  | 312,887 |  |  | $ | 1.72 |
$ | 2.23 - $2.60 |  |  |  | 313,068 |  |  |  | 4.84 |  |  | $ | 2.26 |  |  |  | 312,943 |  |  | $ | 2.26 |
$ | 2.76 - $3.50 |  |  |  | 25,500 |  |  |  | 7.95 |  |  | $ | 3.49 |  |  |  | 12,906 |  |  | $ | 3.48 |
$ | 3.95 |  |  |  | 370,000 |  |  |  | 4.00 |  |  | $ | 3.95 |  |  |  | 370,000 |  |  | $ | 3.95 |
$ | 4.08 - $6.30 |  |  |  | 578,850 |  |  |  | 5.71 |  |  | $ | 5.76 |  |  |  | 525,027 |  |  | $ | 5.85 |
$ | 6.81 - $7.37 |  |  |  | 388,995 |  |  |  | 6.27 |  |  | $ | 7.30 |  |  |  | 297,495 |  |  | $ | 7.30 |
$ | 7.52 - $7.79 |  |  |  | 221,823 |  |  |  | 8.33 |  |  | $ | 7.61 |  |  |  | 49,323 |  |  | $ | 7.66 |
$ | 7.87 |  |  |  | 600,000 |  |  |  | 3.33 |  |  | $ | 7.87 |  |  |  | 300,000 |  |  | $ | 7.87 |
$ | 7.89 - $8.98 |  |  |  | 92,673 |  |  |  | 7.47 |  |  | $ | 8.16 |  |  |  | 48,048 |  |  | $ | 8.22 |
$ | 8.99 |  |  |  | 180,000 |  |  |  | 1.09 |  |  | $ | 8.99 |  |  |  | 180,000 |  |  | $ | 8.99 |
$ | 1.47 - $8.99 |  |  |  | 3,083,796 |  |  |  | 5.01 |  |  | $ | 5.76 |  |  |  | 2,408,629 |  |  | $ | 5.29 |
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY | A summary of the Company’s RSU activity (including performance stock units) and related information for the three months ended March 31, 2022 is as follows: SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY
|  | Number of RSUs |  |  | Weighted Average Grant Date Fair Value |
RSUs unvested - January 1, 2022 |  |  | 2,233,202 |  |  | $ | 6.78 |
RSUs granted |  |  | - |  |  | $ | - |
RSUs vested |  |  | (144,644 | ) |  | $ | 6.57 |
RSUs cancelled/forfeited |  |  | - |  |  |  | - |
RSUs unvested at March 31, 2022 |  |  | 2,088,558 |  |  | $ | 6.79 |
SCHEDULE OF WARRANTS ACTIVITY | A summary of warrant activity for the three months ended March 31, 2022 is as follows: SCHEDULE OF WARRANTS ACTIVITY
|  | Number of Shares Subject to Warrants Outstanding |  |  | Weighted Average Exercise Price |
Warrants outstanding - January 1, 2022 |  |  | 373,847 |  |  | $ | 2.08 |
Granted |  |  | - |  |  |  |  |
Exercised |  |  | - |  |  |  |  |
Expired |  |  | - |  |  |  |  |
Warrants outstanding and exercisable - March 31, 2022 |  |  | 373,847 |  |  | $ | 2.08 |
Weighted average remaining contractual life of the outstanding warrants in years - March 31, 2022 |  |  | 2.3 |  |  |  |  |
SCHEDULE OF WARRANTS OUTSTANDING AND WARRANTS EXERCISABLE | Warrants outstanding and exercisable as of March 31, 2022 are as follows: SCHEDULE OF WARRANTS OUTSTANDING AND WARRANTS EXERCISABLE
Warrant Series |  | Issue Date |  | Warrants Outstanding |  |  | Exercise Price |  |  | Expiration Date
Lender warrants |  | 7/19/2017 |  |  | 373,847 |  |  | $ | 2.08 |  |  | 7/19/2024
SCHEDULE OF STOCK BASED COMPENSATION GRANTED TO EMPLOYEES DIRECTORS CONSULTANTS | The Company recorded stock-based compensation related to equity instruments granted to employees, directors and consultants as follows: SCHEDULE OF STOCK BASED COMPENSATION GRANTED TO EMPLOYEES DIRECTORS CONSULTANTS
|  | For the Three Months Ended |
|  | March 31, |
|  | 2022 |  |  | 2021 |
Employees - selling, general and administrative |  | $ | 1,676,000 |  |  | $ | 755,000 |
Employees – research and development |  |  | 186,000 |  |  |  | - |
Directors - selling, general and administrative |  |  | 100,000 |  |  |  | 100,000 |
Consultants – research and development |  |  | 54,000 |  |  |  | - |
Total |  | $ | 2,016,000 |  |  | $ | 855,000 |

X
- Definition Schedule of Warrants Outstanding [Table Text Block] + References No definition available. + Details
Name: | HROW_ScheduleofWarrantsOutstandingTableTextBlock
Namespace Prefix: | HROW_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration